GB2414668B - Tetracycline modified release delivery system - Google Patents

Tetracycline modified release delivery system

Info

Publication number: GB2414668B
Authority: GB; United Kingdom
Prior art keywords: delivery system; modified release; release delivery; tetracycline; tetracycline modified
Prior art date: 2004-06-03
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Lifetime

Inventor

Victor Pevzner

Marina Ruderman

Avi Avramoff

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Dexcel Ltd Israel

Original Assignee

Dexcel Ltd Israel

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-06-03

Filing date

2004-09-02

Publication date

2009-07-29

2004-09-02Application filed by Dexcel Ltd IsraelfiledCriticalDexcel Ltd Israel

2004-10-06Publication of GB0419500D0publicationCriticalpatent/GB0419500D0/en

2005-12-07Publication of GB2414668ApublicationCriticalpatent/GB2414668A/en

2009-07-29Application grantedgrantedCritical

2009-07-29Publication of GB2414668BpublicationCriticalpatent/GB2414668B/en

2024-09-02Anticipated expirationlegal-statusCritical

StatusExpired - Lifetimelegal-statusCriticalCurrent

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/65—Tetracyclines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)

GB0419500A2004-06-032004-09-02Tetracycline modified release delivery systemExpired - LifetimeGB2414668B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US57630604P	2004-06-03	2004-06-03

Publications (3)

Publication Number	Publication Date
GB0419500D0 GB0419500D0 (en)	2004-10-06
GB2414668A GB2414668A (en)	2005-12-07
GB2414668Btrue GB2414668B (en)	2009-07-29

Family

ID=33159923

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GB0419500AExpired - LifetimeGB2414668B (en)	2004-06-03	2004-09-02	Tetracycline modified release delivery system

Country Status (1)

Country	Link
GB (1)	GB2414668B (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8252776B2 (en)	2007-04-02	2012-08-28	Medicis Pharmaceutical Corporation	Minocycline oral dosage forms for the treatment of acne
US8268804B2 (en)	2005-06-24	2012-09-18	Medicis Pharmaceutical Corporation	Minocycline oral dosage forms for the treatment of acne
US8722650B1 (en)	2005-06-24	2014-05-13	Medicis Pharmaceutical Corporation	Extended-release minocycline dosage forms
US9561241B1 (en)	2011-06-28	2017-02-07	Medicis Pharmaceutical Corporation	Gastroretentive dosage forms for minocycline
JP2017517592A (en)*	2014-04-08	2017-06-29	ダウグローバルテクノロジーズエルエルシー	Dispersion containing esterified cellulose ether

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1858488B2 (en)	2005-03-14	2022-07-20	Wyeth LLC	Tigecycline compositions and methods of preparation
US9192615B2 (en)	2008-08-06	2015-11-24	Medicis Pharmaceutical Corporation	Method for the treatment of acne and certain dosage forms thereof
US7544373B2 (en)	2007-04-02	2009-06-09	Medicis Pharmaceutical Corporation	Minocycline oral dosage forms for the treatment of acne
US7541347B2 (en)	2007-04-02	2009-06-02	Medicis Pharmaceutical Coropration	Minocycline oral dosage forms for the treatment of acne
US7919483B2 (en)	2005-06-24	2011-04-05	Medicis Pharmaceutical Corporation	Method for the treatment of acne
AU2006331688A1 (en)*	2005-12-22	2007-07-05	Wyeth	Oral formulations comprising tigecycline
EP2298324A1 (en)*	2006-01-24	2011-03-23	Paratek Pharmaceuticals, Inc.	Methods of increasing oral bioavailability of tetracyclines
WO2008121107A1 (en)*	2007-04-02	2008-10-09	Medicis Pharmaceutical Corporation	Minocycline oral dosage forms for the treatment of acne
US20120027855A1 (en)*	2007-07-06	2012-02-02	Lupin Limited	Pharmaceutical compositions for gastrointestinal drug delivery
PT2271348T (en)*	2008-03-28	2018-04-16	Paratek Pharm Innc	FORMULATION OF ORAL TETRACYCIN COMPOUND TABLET
DE102011075354A1 (en)*	2011-05-05	2012-11-08	Hennig Arzneimittel Gmbh & Co. Kg	Dosage form comprises at least one first active substance-containing unit, and at least one second active substance-containing unit, and both units comprise a first active substance
WO2012150246A1 (en)	2011-05-05	2012-11-08	Hennig Arzneimittel Gmbh & Co. Kg	Dosage form for the controlled release of active ingredients
US11103517B2 (en)	2015-04-07	2021-08-31	Dr. Reddy's Laboratories Ltd.	Pharmaceutical compositions for minocycline
CN105534941A (en)*	2016-01-04	2016-05-04	浙江美华鼎昌医药科技有限公司	Minocycline hydrochloride sustained release tablets and preparation method
CN119732960B (en)*	2025-03-05	2025-05-09	福安药业集团宁波天衡制药有限公司	Minocycline hydrochloride capsule and preparation method thereof

Citations (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0310814A2 (en)*	1987-10-06	1989-04-12	American Cyanamid Company	Novel controlled release formulations of tetracycline compounds
EP0418565A2 (en)*	1989-09-21	1991-03-27	American Cyanamid Company	Pulsatile once-a-day delivery system for minocycline
EP0558913A1 (en)*	1992-03-02	1993-09-08	American Cyanamid Company	Improved pulsatile once-a-day delivery systems for minocycline
US20020136766A1 (en)*	2000-02-24	2002-09-26	Rudnic Edward M.	Tetracycline antibiotic product, use and formulation thereof

2004
- 2004-09-02GBGB0419500Apatent/GB2414668B/ennot_activeExpired - Lifetime

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0310814A2 (en)*	1987-10-06	1989-04-12	American Cyanamid Company	Novel controlled release formulations of tetracycline compounds
EP0418565A2 (en)*	1989-09-21	1991-03-27	American Cyanamid Company	Pulsatile once-a-day delivery system for minocycline
EP0558913A1 (en)*	1992-03-02	1993-09-08	American Cyanamid Company	Improved pulsatile once-a-day delivery systems for minocycline
US20020136766A1 (en)*	2000-02-24	2002-09-26	Rudnic Edward M.	Tetracycline antibiotic product, use and formulation thereof

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8268804B2 (en)	2005-06-24	2012-09-18	Medicis Pharmaceutical Corporation	Minocycline oral dosage forms for the treatment of acne
US8722650B1 (en)	2005-06-24	2014-05-13	Medicis Pharmaceutical Corporation	Extended-release minocycline dosage forms
US8252776B2 (en)	2007-04-02	2012-08-28	Medicis Pharmaceutical Corporation	Minocycline oral dosage forms for the treatment of acne
US9561241B1 (en)	2011-06-28	2017-02-07	Medicis Pharmaceutical Corporation	Gastroretentive dosage forms for minocycline
JP2017517592A (en)*	2014-04-08	2017-06-29	ダウグローバルテクノロジーズエルエルシー	Dispersion containing esterified cellulose ether

Also Published As

Publication number	Publication date
GB0419500D0 (en)	2004-10-06
GB2414668A (en)	2005-12-07

Publication	Publication Date	Title
PL2484223T3 (en)	2019-09-30	Controlled release oral delivery systems
GB0420016D0 (en)	2004-10-13	Controlled release oral delivery system
GB2414668B (en)	2009-07-29	Tetracycline modified release delivery system
EP1865925A4 (en)	2012-01-18	Buccal delivery system
EP1901796A4 (en)	2011-01-05	Drug delivery system
GB0412796D0 (en)	2004-07-14	Supawall system
EP1708407A4 (en)	2014-03-26	Mixnet system
GB0421837D0 (en)	2004-11-03	Catalyst delivery system
GB0517035D0 (en)	2005-09-28	Delivery system
EP1761250A4 (en)	2007-05-09	Oral delivery system
GB2422315B (en)	2009-11-11	Maggot delivery system
GB0425964D0 (en)	2004-12-29	System
EP1807810A4 (en)	2010-02-24	Cash-handling system
GB0515363D0 (en)	2005-08-31	Drug delivery system
GB0409627D0 (en)	2004-06-02	Fabron fabloc system
PL114959U1 (en)	2006-01-09	Delivery system
GB0505779D0 (en)	2005-04-27	Drug release system
GB0416749D0 (en)	2004-09-01	Braking systems
GB0419412D0 (en)	2004-10-06	Phonecard system
GB0519069D0 (en)	2005-10-26	Delivery system
GB0525355D0 (en)	2006-01-18	Delivery system
GB0425587D0 (en)	2004-12-22	Maggot delivery system
GB0404478D0 (en)	2004-03-31	Delivery systems
GB0421600D0 (en)	2004-10-27	Catalyst delivery system
GB2410485B (en)	2007-04-11	Medicament delivery system

Legal Events

Date	Code	Title	Description
2024-09-25	PE20	Patent expired after termination of 20 years	Expiry date:20240901

Movatterモバイル変換

GB2414668B - Tetracycline modified release delivery system - Google Patents

Info

Links

Classifications

Landscapes

Applications Claiming Priority (1)

Publications (3)

Family

ID=33159923

Family Applications (1)

Country Status (1)

Cited By (5)

Families Citing this family (15)

Citations (4)

Patent Citations (4)

Cited By (5)

Also Published As

Similar Documents

Legal Events